ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,087Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 1006

$782K Total Retail Price of All Prescriptions

Rank: 84 out of 1006

476 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,618 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 536 499 1 4
LEVOTHYROXINE SODIUM 518 486 2 2
SIMVASTATIN 469 430 3 1
LISINOPRIL 432 377 4 3
HYDROCHLOROTHIAZIDE 312 282 5 11
ATORVASTATIN CALCIUM 275 247 6 5
OMEPRAZOLE 270 236 7 9
FUROSEMIDE 269 237 8 6
PRAVASTATIN SODIUM 258 223 9 15
CRESTOR 254 219 10 18
METFORMIN HCL 240 207 11 10
DIOVAN 205 190 12 16
ATENOLOL 193 176 13 13
WARFARIN SODIUM 170 162 14 8
PANTOPRAZOLE SODIUM 168 164 15 32
METOPROLOL SUCCINATE 164 153 16 12
ZOLPIDEM TARTRATE 148 129 17 14
LOSARTAN POTASSIUM 147 131 18 22
HYDROCODONE-ACETAMINOPHEN 130 101 S3 19 25
GABAPENTIN 126 106 20 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 95 21 38
METOPROLOL TARTRATE 119 113 22 7
JANUVIA 118 109 23 49
DONEPEZIL HCL 113 113 24 17
CITALOPRAM HBR 112 82 25 24
OXYCODONE-ACETAMINOPHEN 111 65 S2 26 57
NEXIUM 110 98 27 28
ALLOPURINOL 105 105 28 31
MIRTAZAPINE 95 95 29 26
FLUOXETINE HCL 92 83 30 85
SPIRIVA 89 88 31 48
CARVEDILOL 85 74 32 36
ZETIA 82 60 33 51
ENDOCET 79 63 S2 34 248
SERTRALINE HCL 76 68 35 19
ESCITALOPRAM OXALATE 75 71 36 27
TRAZODONE HCL 74 73 37 21
LABETALOL HCL 74 69 37 164
DOXAZOSIN MESYLATE 73 73 39 87
METFORMIN HCL ER 73 57 39 56
ACTOS 71 59 41 89
TAMSULOSIN HCL 70 57 42 23
FLUTICASONE PROPIONATE 68 61 43 55
FENTANYL 68 68 S2 43 74
CYMBALTA 66 66 45 41
ADVAIR DISKUS 65 56 46 37
TRIAMTERENE-HCTZ 64 64 47 58
ATELVIA 63 50 48 182
POTASSIUM CHLORIDE 62 49 49 30
ISOSORBIDE MONONITRATE ER 61 61 50 59
DIOVAN HCT 60 60 51 60
DIVALPROEX SODIUM 60 0 51 53
ALENDRONATE SODIUM 60 60 51 29
VYTORIN 57 46 54 145
CLOPIDOGREL 56 56 55 46
ENALAPRIL MALEATE 56 56 55 83
LOSARTAN-HYDROCHLOROTHIAZIDE 53 51 57 81
KLOR-CON M20 53 49 57 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.